Navigation Links
Importance of policy action to help reduce HCV-related deaths across Europe by 2025
Date:3/31/2011

New findings from two modeling studies presented at the International Liver Congress support the call to action from medical experts and patients in relation to the challenge health inequalities represent in the diagnosis and access to HCV treatment.

The first modelling study looks at current treatment practices and available epidemiological data across a number of EU countries (including Belgium, France, Germany, Italy, Spain and the UK), and shows that based on current practice HCV-related morbidity and mortality (linked to liver cancer deaths) will be reduced by 10% over nine years (2012 2021). In addition, the incidence of cirrhosis will also be reduced by 16%. Both results take into consideration variations across countries in screening, diagnosis and treatment standards.

The study also considered HCV progression if 70% of treatment naive patients and all non-responders and relapsers were treated with a protease inhibitor from 2012 onwards (increasing average SVR to 70% and 60.5% in non-responders and treatment-naive genotype 1 patients respectively). Based on this scenario, findings show that the overall HCV-related mortality would decrease by a further 12% over the same period, corresponding to a relative impact of 117% compared to current practice.

Based on these forecasts, experts conclude that the development and implementation of ambitious policy strategies to ensure effective access to diagnosis and treatment alongside the availability of new therapies (such as proteases inhibitors) could have a major impact in further reducing HCV-related mortality in the future.

A second modelling study looked at French health resource allocation and how this may change with the introduction of triple therapy for non-responders in the near future. In France, the data show the number of patients eligible for treatment (treatment-naive and previous non-responders) will increase two to three folds, which equates to an additional 9,900 to 14,300 patients by 2012.

This demonstrates the need to adjust allocation of health resources at national level to meet this demand.

Mark Thursz, EASL's Vice-Secretary commented: "These types of modelling studies are useful in providing us with data to support our policy efforts with political audiences. We have been saying, alongside patients, that the current challenges to managing viral hepatitis effectively are linked to a wide discrepancy in diagnosis and treatment standards across the different Member States. Now we can build a stronger case when discussing the development of effective health strategies within the EU and at Member State level. The good news is that antiviral treatments are being proven to be effective in substantially reducing HCV-related mortality in Europe. We must strengthen our efforts towards a better identification of carriers needing management and treatment."

HCV is a major cause of acute hepatitis and chronic liver disease. Globally, an estimated 130� million people are chronically infected with HCV and 3𔃂 million are newly infected each year.


'/>"/>

Contact: Isabelle Scali
easlpressoffice@cohnwolfe.com
44-771-743-5103
European Association for the Study of the Liver
Source:Eurekalert

Related medicine news :

1. PDA Reminds Parents About the Importance of Childrens Oral Health
2. Dental Students Learn Importance of Legislative Process to Profession
3. Recent Earthquakes Across the World Underscore the Importance of Emergency Preparedness Supplies and Survival Kits for Individuals, Families and Businesses
4. HCG True Diet – Dr. Robert True Speaks About the Importance of Medical Supervision for HCG Diets
5. Breast cancer screening program should give higher importance to younger women
6. Study evaluates importance of timeliness of care in breast cancer diagnosis and treatment
7. Water Community Stresses Importance of Security During Drinking Water Week
8. Trupanion Emphasizes the Importance of Pet Insurance for Small Pets
9. Preschool depression: The importance of early detection of depression in young children
10. Childhood Obesity Institute Symposium at Children's National Medical Center Zeroes in on the Importance of Multi-Disciplinary Approach to Curb Childhood Obesity
11. ‘Protein Lady' Announces New Blog to Promote Importance of Protein-Rich Diet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... SAN DIEGO , Sept. 22, 2017 ... ll medical device is now successfully helping those with ... Union. Fibromyalgia diagnosed Amanda in ... getting dressed and washing my hair, experiencing no sleep ... body in painful spasm… I cannot recommend [the AVACEN ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
Breaking Medicine Technology: